Lobbying client

WESTPORT PHARMACEUTICALS, LLC

product development and manufacturing of pharmaceutical and nutritional products

Filings
15
Filed by
1
Reported in-house
—
Reported by firms
$30,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2013 to 2016

Filings

15 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2016
THE CHARLES GROUP, LLC — reported
4th Quarter - Report
4th Quarter 2015
THE CHARLES GROUP, LLC — reported
3rd Quarter - Report
3rd Quarter 2015
THE CHARLES GROUP, LLC — reported
2nd Quarter - Report
2nd Quarter 2015
THE CHARLES GROUP, LLC — reported
1st Quarter - Report
1st Quarter 2015
THE CHARLES GROUP, LLC — reported
4th Quarter - Report
4th Quarter 2014
THE CHARLES GROUP, LLC — reported
3rd Quarter - Amendment
3rd Quarter 2014
THE CHARLES GROUP, LLC — reported
3rd Quarter - Reportreplaced
3rd Quarter 2014
THE CHARLES GROUP, LLC — reported
2nd Quarter - Report
2nd Quarter 2014
THE CHARLES GROUP, LLC $10,000 reported
1st Quarter - Amendment
1st Quarter 2014
THE CHARLES GROUP, LLC $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE CHARLES GROUP, LLC 13 $30,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Science/Technology SCI 14

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.